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Background
We have previously documented abnormalities in cardiac
structure in patients with adult-onset growth hormone
deficiency (GHD) and acromegaly which partially resolved
during treatment (Dattani et al. 2012, Zemrak et al. 2012).
No treatment effect was seen on global measures of
cardiac function e.g. left ventricular ejection fraction.
The aim of this study was to use quantitative strain
parameters from cardiac magnetic resonance (CMR) myo-
cardial feature tracking (FT) to assess regional changes in
function before and after treatment in patients with GHD
and acromegaly.
Methods
10 patients with GHD, 13 patients with acromegaly and 23
age- and sex-matched normal controls underwent CMR.
Patients underwent scanning before and again 12 months
after treatment. Radial and circumferential strain para-
meters were derived from 2-chamber (2CH), 4-chamber
(4CH) and basal, mid and apical short axis cine-images
using dedicated FT software (Diogenes MRI, TomTec
Imaging Systems, Munich, Germany). Comparisons
between groups were performed using the T-test.
Results
There were no significant differences in any FT derived
parameters between normal controls and patients with
GHD.
There was a significant difference in 4CH-circumferen-
tial strain in patients with acromegaly compared to normal
controls (-7.6% vs -5.0%, p=0.01). There were no signifi-
cant differences in the remaining parameters.
The effect of treatment on FT derived indices is shown
in Tables 1 and 2.
Conclusions
Other than 4-CH circumferential strain, no differences
were seen in any FT derived strain measurements between
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Table 1 The effect on feature-tracking parameters before and after one year of treatment in acromegaly patients.
Feature-tracking
Parameters
2C Pre 2C Post 4C Pre 4C Post Basal Pre Basal Post Mid Pre Mid Post Apex Pre Apex Post
Radial Strain (%) 16.6 ± 6.9 14.9 ± 5.2 13.1 ± 6.3 15.1 ± 3.9 22.2 ± 14.4 20.0 ± 5.7 18.7 ± 7.7 16.1 ± 6.0 17.1 ± 5.8 19.5 ± 15.9
Circumferential
Strain (%)
-7.17 ± 2.8 -7.23 ± 2.4 -7.55 ± 1.9 -5.69 ± 2.0 -9.87 ± 2.3 -10.4 ± 1.6 -9.19 ± 3.0 -8.86 ± 2.3 -9.99 ± 2.7 -10.6 ± 3.4
The values represent mean ± 1SD Abbreviation: 2C - 2 Chambers, 4C - 4 Chambers, Pre - Pretreatment, Post - Post-treament
Javaid et al. Journal of Cardiovascular Magnetic
Resonance 2013, 15(Suppl 1):E55
http://www.jcmr-online.com/content/15/S1/E55
© 2013 Javaid et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
patients with GHD and normal controls, patients with
acromegaly and normal controls and following 12 months
of treatment.
The structural changes seen in patients with acrome-
galy and GHD deficiency may, therefore, precede signifi-
cant functional abnormalities. Early identification and
treatment of these patients may prevent the development
of functionally important myocardial damage.
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Table 2 The effect on feature-tracking parameters before and after one year of treatment in GHD patients.
Feature-tracking
Parameters
2C Pre 2C Post 4C Pre 4C Post Basal Pre Basal Post Mid Pre Mid Post Apex Pre Apex Post
Radial Strain (%) 16.3 ± 5.8 19.4 ± 5.2 14.8 ± 5.2 14.0 ± 6.5 20.5 ± 8.1 19.4 ± 7.5 17.0 ± 5.4 15.1 ± 2.2 19.0 ± 9.0 16.1 ± 8.6
Circumferential
Strain (%)
-7.83 ± 1.7 -7.59 ± 2.05 -6.07 ± 3.4 -4.72 ± 5.3 -10.7 ± 2.6 -10.2 ± 2.6 -8.43 ± 4.2 -9.25 ± 2.5 -9.62 ± 2.7 -8.84 ± 3.3
The values represent mean ± 1SD Abbreviation: 2C - 2 Chambers, 4C - 4 Chambers, Pre - Pretreatment, Post - Post-treatment
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